Newsroom

Sorted by: Latest

-

Verantum Launches HVAC IQ Capital Planning, a New-to-Industry Approach to Condition-Based Asset Lifecycle Management

IRVINE, Calif.--(BUSINESS WIRE)--Verantum, a leader in building intelligence and HVAC-R asset optimization, announced the launch of HVAC IQ Capital Planning, a significant expansion of its HVAC IQ platform and a major step in the company’s Pillar 3 strategy for condition-based asset lifecycle management. Designed for multi-site retailers and commercial building operators, the new capability enables smarter, data-driven capital investment decisions by combining real-time and historical HVAC perf...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 15.07.2026 LANDXN.LN IE000RN036E0 34,035.00 USD 756,577.13 22.229  ...
-

Butterfly Network to Report Second Quarter 2026 Financial Results on July 30, 2026

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced that it will report second quarter 2026 financial results on Thursday, July 30, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcast...
-

Kind Designs Closes Oversubscribed $10M Round to Scale 3D-Printed Living Seawalls

MIAMI--(BUSINESS WIRE)--Kind Designs set out to raise $5 million. Nearly $20 million in investor interest pushed the company to double the round. Today, the Miami-based climate resilience company announced the close of a $10 million Pre-Series A at a $70 million valuation, bringing the company’s total funding to date to $21.5 million. As coastal communities race to replace aging shoreline infrastructure with more resilient solutions, demand for Kind Designs' 3D-printed Living Seawalls has accel...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Innovative Transaction & Process UCITS ETF 15.07.2026 LEGR LN IE00BF5DXP42 950,002.00 USD 50,925,602.81 53.606  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NASDAQ Clean Edge Green Energy UCITS ETF 15.07.2026 QCLN.LN IE00BDBRT036 2,475,002.00 USD 52,243,320.46 21.108  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx NextG UCITS ETF 15.07.2026 NXTG.LN IE00BWTNM743 170,002.00 USD 9,243,392.17 54.372  ...
-

Introducing Lee LQD, Liquid Soft Denim Designed for the Way Women Move 

GREENSBORO, N.C.--(BUSINESS WIRE)--Today, Lee®, the iconic American denim brand, launches Lee LQD Denim, a new collection available in the US and Europe. Tailored from premium fabric that feels almost liquid on the body, the pieces drape beautifully offering a clean, modern silhouette that moves with you all day long.For decades, Lee has offered female denim assortments that bridge timeless style and quality with modern fits. Lee LQD Denim is the latest expression of that legacy, combining eleva...
-

Negev Labs Announces Name Change to Palomar Labs

NEW YORK & VIENNA--(BUSINESS WIRE)--Negev Labs, the venture builder behind a portfolio of companies developing therapies for the brain, today changed its name to Palomar Labs...
-

CryoTherapeutics Announces First Patient Treated in ICECAP Clinical Trial Evaluating Localized Cryotherapy for Coronary Artery Disease

LIÈGE, Belgium--(BUSINESS WIRE)--CryoTherapeutics, a medical device company developing minimally invasive localized cryotherapy for the treatment of coronary artery disease, today announced the successful treatment of the first patient in its ICECAP clinical trial. The milestone marks an important step in evaluating whether localized cryotherapy can help stabilize vulnerable coronary plaques before they lead to myocardial infarction. During ICECAP screening, the first patient with stable angina...